Renal Biomarker Market Type, Demand, Application

Renal Biomarker Market Type, Demand, Application, Current Scenario and Global
Industry Analysis 2018-2025
Renal Biomarker accounted to USD XX.XX million in 2017 growing at a CAGR of XX.XX% during the
forecast period of 2018 to 2025. Global Renal biomarker market report contains data for historic
years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Get Sample Copy of This Market Information: http://databridgemarketresearch.com/request-asample/?dbmr=global-renal-biomarker-market
Renal biomarkers are used in diagnosis of diseases acute or chronic kidney injuries. The renal
biomarkers measures the blood and urine level, detect pre-renal, intrinsic and post renal
kidney injuries. The renal biomarker market is highly fragmented and is based on new
product launches and clinical results of products. Some of the major players operating in
renal biomarker market are
Abbott Laboratories
Alere Inc.
Siemens Healthcare
Roche Diagnostics Corporation
Beckman Coulter Inc.
Randox Laboratories Ltd.
Thermo Fisher Scientific, Inc.
BIOPORTO A/S
Astute Medical, Inc.
F. Hoffmann-La Roche AG
BioMérieux SA
others
The major renal biomarker players have used various strategies such as new product
launches, clinical trials, market initiatives, high expense on research and development,
agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints
in this market. The report includes market shares of renal biomarker market for global,
Europe, North America, Asia Pacific and South America.
Get Full TOC: https://databridgemarketresearch.com/toc/?dbmr=global-renalbiomarker-market
By type the market for renal biomarker is segmented into
Functional biomarker
up-regulated proteins
Low molecular weight protein
Enzymes
The functional biomarker segment is further sub-segmented into ion serum creatinine,
serum cystatin c, urine albumin.

up-regulated proteins segment is sub-segmented into neutrophil gelatinase-associated
lipocalin, kidney injury molecule-1, liver-type fatty acid–binding protein, interleukin-
18, β-trace protein, and asymmetric dimethylarginine.
The enzymes segment is further sub-segmented into N-acetyl-glucosaminidase,
glutathione-s-transferase, gamma-glutamyl transpeptidase, alanine aminopeptidase,
lactate dehydrogenase.
By product type the renal biomarker market is segmented into
Enzyme linked immunosorbent assay
Particle-enhanced turbidimetric immunoassay
Colorimetric assay
Chemiluminescent enzyme immunoassay
Liquid chromatography-mass spectrometry, others
On the basis of end-users the renal biomarker market is segmented into
Hospitals
Clinics
Research center
Diagnostic labs
On the basis of geography, renal biomarker market report covers data points for 28
countries across multiple geographies such as North America & South America, Europe,
Asia-Pacific, and Middle East & Africa.
Some of the major countries covered in this report are U.S., Canada, Germany, France,
U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan,
Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others.
North America is expected to dominate the market.
Major Market Drivers and Restraints:
Increasing incidences of kidney related diseases
Increasing prevalence of multiple co-morbidities
R&D investments in field of genetics
Weak reimbursements
Stringent regulatory framework
Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-beforebuying/?dbmr=global-renal-biomarker-market
About Us
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our
hard work with certitude. For Customization or Getting Discount on Report by emailing

sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client
satisfying rate.
Contact Us
Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
http://databridgemarketresearch.com